Medicine fell foul of regulators despite helping patients, as it required large dose. Now, Technion's pinpoint delivery system cuts quantity needed, allowing revival of drug

From Waze to cancer-busting nano-ghost cells and 3-D printed hearts, The Times of Israel takes a dive into tech that helps us get where we're going and keeps us safe and healthy

aMoon fund, a health-tech fund, makes a $5 million investment in venture set up by Technion's Marcelle Machluf to commercialize tumor-busting technology